Tag: Parkinson’s
Autism Spectrum Disorder Linked to Increased Risk for Parkinson Disease
Association seen even after adjustment for sex, socioeconomic status, family history of mental illness and PD, age at autism diagnosis
Ultraprocessed Food Consumption Linked to Nonmotor Prodromal Parkinson Disease
Odds of having three or more versus zero prodromal features increased when comparing extreme quintiles of UPF intake
Common Medications Tied to Older Age at Onset of Parkinson Disease
Almost 10-year delay seen for patients who were started on adrenergic blockers before onset of PD symptoms
AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
Significant reduction also seen in change from baseline in daily OFF times versus placebo
Globally, 25.2 Million Projected to Be Living With Parkinson Disease in 2050
Primary contributor to increase in cases from 2021 to 2050 is population aging, followed by population growth
AAN: Obstructive Sleep Apnea Linked to Increased Incidence of Parkinson Disease
Incidence of Parkinson disease significantly lower with early CPAP treatment, but no reduction seen with late CPAP treatment
Study Finds Exenatide Not Beneficial for Parkinson Disease
No evidence seen to support GLP-1 receptor agonist exenatide as disease-modifying treatment for Parkinson disease
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease
Hearing Impairment Tied to Higher Risk for New Parkinson Disease Diagnosis
In a recent study, risk increased 57 percent for every 10-dB increase in speech-reception threshold
Multiple Penicillin Courses Linked to Modestly Lower Risk for Parkinson Disease
Increase in PD risk seen in association with exposure to two or more courses of antifungals one to five years prior
